Novartis AG is 176.3x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($283.13 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRDN | NVS |
|---|---|---|
| Market cap | $1.61 B | $283.13 B |
| US-listed rank | #2271 | #47 |
| Revenue (latest FY) | $4.00M | - |
| Net income (latest FY) | -$342.60M | - |
| Net margin | -8558.6% | - |
| SEC filings | 794 | 947 |
Novartis AG is 176.3x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($283.13 B vs $1.61 B).
Full pages: Viridian Therapeutics, Inc.DE and Novartis AG, or browse the full rankings.